“There’s no reason she needed to deliver that line herself. It’s a character with a mask and no visible mouth, it could easily have been dubbed over,” one critic wrote on Reddit. Another ...

“This is part of our commitment to a thorough and transparent investigation ... Edison said in February that its lines over Eaton Canyon saw a momentary increase of electrical current ...

The two exceptions were “The Song Is Over” and “Goin’ Mobile.” It took 54 years and more than 1,000 concerts, but they finally broke out “The Song Is Over” Sunday evening at London ...

Few exhibitions at the moment could be more timely than Degenerate Art: Modern Art on Trial Under ... as it toured around Germany and Austria over the next few years, making it one of the most ...

The subsequent outflows were prompted by concerns over slowing corporate earnings, with growth decelerating due to weakening urban demand and modest income increases. Additionally, global trade ...

HONG KONG – With an estimated 80,000 people shuttling among events during Hong Kong’s art week from March 24 ... The Shadow Of The Cosmic four times over the course of the week.

There’s a whole lot to admire in this project. The swing-out transparent OLED display is super slick, the electronics are housed on a single PCB, the back half of the grip is in fact a portable ...

Simpsons-inspired AI edits are making waves on social media alongside the Studio Ghibli trend. Several users are experimenting with the feature, and the results have left them amazed. Simpsons ...

By Julia Jacobs Over nearly six decades ... The Museum of Modern Art in New York is promoting Christophe Cherix, the chief curator of its drawings and prints department. It will be his first ...

The Portland Museum of Art wants to raze it to make way for a sweeping glass-and-timber expansion on that site, but Greater Portland Landmarks filed a lawsuit last year to save the building at 142 ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa ...